📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

A universal cannabinoid CB1 and CB2 receptor TR-FRET kinetic ligand-binding assay. (2025)

First Author: Borrega-Roman L

Attributed to: Role of pharmacological activity of autoantibodies in ME/CFS funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3389/fphar.2025.1469986

PubMed Identifier: 40271066

Publication URI: http://europepmc.org/abstract/MED/40271066

Type: Journal Article/Review

Volume: 16

Parent Publication: Frontiers in pharmacology

ISSN: 1663-9812